{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:49:04Z","timestamp":1789937344654,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,2,27]],"date-time":"2010-02-27T00:00:00Z","timestamp":1267228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s11910-010-0096-4","type":"journal-article","created":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T04:02:26Z","timestamp":1267156946000},"page":"118-126","source":"Crossref","is-referenced-by-count":141,"title":["A Diagnostic Algorithm for Metabolic Myopathies"],"prefix":"10.1007","volume":"10","author":[{"given":"Andres","family":"Berardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"DiMauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,27]]},"reference":[{"key":"96_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0887-8994(99)00133-2","volume":"22","author":"BT Darras","year":"2000","unstructured":"Darras BT, Friedman NR: Metabolic myopathies: a clinical approach: part I. Pediatr Neurol 2000, 22:87\u201397.","journal-title":"Pediatr Neurol"},{"key":"96_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/CND.0b013e3181903126","volume":"10","author":"BA Adel van","year":"2009","unstructured":"\u2022 van Adel BA, Tarnopolsky MA: Metabolic myopathies: update 2009. J Clin Neuromuscul Dis 2009, 10:97\u2013121. This article reviews the key clinical features, diagnostic tests, and treatment recommendations for the more common metabolic myopathies.","journal-title":"J Clin Neuromuscul Dis"},{"key":"96_CR3","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/mus.1103","volume":"24","author":"S DiMauro","year":"2001","unstructured":"DiMauro S, Lamperti C: Muscle glycogenoses. Muscle Nerve 2001, 24:984\u2013999.","journal-title":"Muscle glycogenoses. Muscle Nerve"},{"key":"96_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0146-0005(99)80046-9","volume":"23","author":"I Tein","year":"1999","unstructured":"Tein I: Neonatal metabolic myopathies. Semin Perinatol 1999, 23:125\u2013151.","journal-title":"Neonatal metabolic myopathies. Semin Perinatol"},{"key":"96_CR5","first-page":"328","volume":"22","author":"B Eymard","year":"2001","unstructured":"Eymard B, Lafor\u00eat P: Metabolic myopathies in adulthood. Features and clues for diagnosis [in French]. Rev Med Interne 2001, 22:328\u2013337.","journal-title":"Rev Med Interne"},{"key":"96_CR6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nmd.2008.12.004","volume":"19","author":"R Spiegel","year":"2009","unstructured":"Spiegel R, Gomez EA, Akman HO, et al.: Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations. Neuromuscul Disord 2009, 19:207\u2013211.","journal-title":"Neuromuscul Disord"},{"key":"96_CR7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMc0901158","volume":"23","author":"T Stojkovic","year":"2009","unstructured":"Stojkovic T, Vissing J, Petit F, et al.: Muscle glycogenosis due to phosphoglucomutase 1 deficiency. N Engl J Med 2009, 23:425\u2013427.","journal-title":"N Engl J Med"},{"key":"96_CR8","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archneur.57.7.923","volume":"57","author":"RG Haller","year":"2000","unstructured":"Haller RG: Treatment of McArdle disease. Arch Neurol 2000, 57:923\u2013924.","journal-title":"Arch Neurol"},{"key":"96_CR9","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.59.9.1395","volume":"59","author":"RG Haller","year":"2002","unstructured":"Haller RG, Vissing J: Spontaneous \u2018second wind\u2019 and glucose-induced second \u2018second wind\u2019 in McArdle disease: oxidative mechanisms. Arch Neurol 2002, 59:1395\u20131402.","journal-title":"Arch Neurol"},{"key":"96_CR10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/brain\/awg028","volume":"126","author":"T Taivassalo","year":"2003","unstructured":"Taivassalo T, Jensen TD, Kennaway N, et al.: The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain 2003, 126:413\u2013423.","journal-title":"Brain"},{"key":"96_CR11","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1212\/01.wnl.0000289190.66955.67","volume":"70","author":"MC \u00d8rngreen","year":"2008","unstructured":"\u00d8rngreen MC, Schelhaas HJ, Jeppesen TD, et al.: Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency? Neurology 2008, 70:1876\u20131882.","journal-title":"Neurology"},{"key":"96_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archneur.62.1.37","volume":"62","author":"M Deschauer","year":"2005","unstructured":"Deschauer M Wieser T, Zierz S: Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects. Arch Neurol 2005, 62:37\u201341","journal-title":"Arch Neurol"},{"key":"96_CR13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.20320","volume":"57","author":"MC \u00d8rngreen","year":"2005","unstructured":"\u00d8rngreen MC, Dun\u00f8 M, Ejstrup R, et al.: Fuel utilization in subjects with carnitine palmitoyl-transferase 2 gene mutations. Ann Neurol 2005, 57:60\u201366.","journal-title":"Ann Neurol"},{"key":"96_CR14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1212\/WNL.62.1.82","volume":"62","author":"RG Haller","year":"2004","unstructured":"Haller RG, Vissing J: No spontaneous second wind in muscle phosphofructokinase deficiency. Neurology 2004, 62:82\u201386.","journal-title":"Neurology"},{"key":"96_CR15","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa031836","volume":"349","author":"J Vissing","year":"2003","unstructured":"Vissing J, Haller RG: The effect of oral sucrose on exercise tolerance in patients with McArdle\u2019s disease. N Engl J Med 2003, 349:2503\u20132509.","journal-title":"N Engl J Med"},{"key":"96_CR16","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/archneur.62.9.1440","volume":"62","author":"J Vissing","year":"2005","unstructured":"Vissing J, Quistorff B, Haller RG: Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency. Arch Neurol 2005, 62:1440\u20131443.","journal-title":"Arch Neurol"},{"key":"96_CR17","first-page":"105","volume":"26","author":"A Toscano","year":"2007","unstructured":"Toscano A, Musumeci O: Tarui disease and distal glycogenoses: clinical and genetic update. Acta Myol 2007, 26:105\u2013107.","journal-title":"Acta Myol"},{"key":"96_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2006.06351.x","volume":"136","author":"E Beutler","year":"2007","unstructured":"Beutler E: PGK deficiency. Br J Haematol 2007, 136:3\u201311.","journal-title":"PGK deficiency. Br J Haematol"},{"key":"96_CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0733-8619(05)70181-X","volume":"18","author":"S Tsujino","year":"2000","unstructured":"Tsujino S, Nonaka I, DiMauro S: Glycogen storage myopathies. Neurol Clin 2000, 18:125\u2013150.","journal-title":"Glycogen storage myopathies. Neurol Clin"},{"key":"96_CR20","doi-asserted-by":"crossref","unstructured":"Regelsberger G, H\u00f6ftberger R, Pickl WF, et al.: Danon disease: case report and detection of new mutation. J Inherit Metab Dis 2009 Jul 7 (Epub ahead of print).","DOI":"10.1007\/s10545-009-1097-9"},{"key":"96_CR21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mus.10520","volume":"29","author":"CJ Klein","year":"2004","unstructured":"Klein CJ, Boes CJ, Chapin JE, et al.: Adult polyglucosan body disease: case description of an expanding genetic and clinical syndrome. Muscle Nerve 2004, 29:323\u2013328.","journal-title":"Muscle Nerve"},{"key":"96_CR22","doi-asserted-by":"crossref","unstructured":"Noel N, Flanagan JM, Ramirez Bajo MJ, et al.: Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain. J Haematol 2006, 132:523\u2013529.","DOI":"10.1111\/j.1365-2141.2005.05882.x"},{"key":"96_CR23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1172\/JCI118799","volume":"98","author":"J Shen","year":"1996","unstructured":"Shen J, Bao Y, Liu HM, et al.: Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 1996, 98:352\u2013357.","journal-title":"J Clin Invest"},{"key":"96_CR24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajmg.c.30087","volume":"142","author":"N Longo","year":"2006","unstructured":"Longo N, Amat di San Filippo C, Pasquali M: Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet 2006, 142:77\u201385.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"96_CR25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/WCO.0b013e32830dd5a6","volume":"21","author":"C Bruno","year":"2008","unstructured":"\u2022 Bruno C, DiMauro S: Lipid storage myopathies. Curr Opin Neurol 2008, 21:601\u2013606. This article provides an excellent update on lipid storage myopathies.","journal-title":"Curr Opin Neurol"},{"key":"96_CR26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.182.4115.929","volume":"182","author":"S DiMauro","year":"1973","unstructured":"DiMauro S, DiMauro PM: Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science 1973, 182:929\u2013931.","journal-title":"Science"},{"key":"96_CR27","first-page":"253","volume":"43","author":"H Hamano","year":"2003","unstructured":"Hamano H, Shinohara Y, Takizawa S, et al.: Very-long-chain acyl-CoA dehydrogenase deficiency presenting with recurrent rhabdomyolysis in an adult. Rinsho Shinkeigaku 2003, 43:253\u2013257.","journal-title":"Rinsho Shinkeigaku"},{"key":"96_CR28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1096-7192(03)00024-6","volume":"78","author":"A Curcoy","year":"2003","unstructured":"Curcoy A, Olsen RK, Ribes A, et al.: Late-onset form of beta-electron transfer flavoprotein deficiency. Mol Genet Metab 2003, 78:247\u2013249.","journal-title":"Mol Genet Metab"},{"key":"96_CR29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/01.wnl.0000194241.35115.7c","volume":"66","author":"R Horvath","year":"2006","unstructured":"Horvath R, Schneiderat P, Schoser BG, et al.: Coenzyme Q10 deficiency and isolated myopathy. Neurology 2006, 66:253\u2013255.","journal-title":"Neurology"},{"key":"96_CR30","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/brain\/awm054","volume":"130","author":"K Gempel","year":"2007","unstructured":"\u2022 Gempel K, Topaloglu H, Talim B, et al.: The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 2007, 130:2037\u20132044. This is the first documentation of ETF-dehydrogenase mutation riboflavin-responsive MADD, indicating that this disorder and the myopathic form of CoQ 10 deficiency may be allelic diseases.","journal-title":"Brain"},{"key":"96_CR31","first-page":"510","volume":"391","author":"T Elston","year":"1998","unstructured":"Elston T, Wang H, Oster G: Energy transduction in ATP synthase. Nature 1998, 391:510\u2013513.","journal-title":"Energy transduction in ATP synthase. Nature"},{"key":"96_CR32","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1074\/jbc.R000021200","volume":"276","author":"H Noji","year":"2001","unstructured":"Noji H, Yoshida M: The rotary machine of the cell, ATP synthase. J Biol Chem 2001, 276:1665\u20131668.","journal-title":"J Biol Chem"},{"key":"96_CR33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.neuro.30.051606.094302","volume":"31","author":"S DiMauro","year":"2008","unstructured":"\u2022 DiMauro S, Schon E: Mitochondrial disorders in the nervous system. Ann Rev Neurosci 2008, 31:91\u2013123. This is an excellent, comprehensive review of mitochondrial diseases.","journal-title":"Ann Rev Neurosci"},{"key":"96_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajmg.1379","volume":"106","author":"A Suomalainen","year":"2001","unstructured":"Suomalainen A, Kaukonen J: Diseases caused by nuclear genes affecting mtDNA stability. Am J Med Genet 2001, 106:53\u201361.","journal-title":"Am J Med Genet"},{"key":"96_CR35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10540-007-9036-1","volume":"27","author":"A Spinazzola","year":"2007","unstructured":"Spinazzola A, Zeviani M: Disorders of nuclear-mitochondrial intergenomic signaling. Biosci Rep 2007, 27:39\u201351.","journal-title":"Biosci Rep"},{"key":"96_CR36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/abbs\/gmn021","volume":"41","author":"X Zhu","year":"2009","unstructured":"Zhu X, Peng X, Guan MX, et al.: Pathogenic mutations of nuclear genes associated with mitochondrial disorders. Acta Biochim Biophys Sin (Shanghai) 2009, 41:179\u2013187.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"96_CR37","first-page":"467","volume":"147","author":"LP Rowland","year":"1991","unstructured":"Rowland LP, Blake DM, Hirano M, et al.: Clinical syndromes associated with ragged red fibers. Rev Neurol 1991, 147:467\u2013473.","journal-title":"Rev Neurol"},{"key":"96_CR38","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1212\/WNL.51.6.1525-a","volume":"51","author":"M Zeviani","year":"1998","unstructured":"Zeviani M, Moraes CT, DiMauro S, et al.: Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1998, 51:1525\u20131533.","journal-title":"Neurology"},{"key":"96_CR39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1196\/annals.1444.011","volume":"1142","author":"DM Sproule","year":"2008","unstructured":"Sproule DM, Kaufmann P: Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 2008, 1142:133\u2013158.","journal-title":"Ann N Y Acad Sci"},{"key":"96_CR40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/348651a0","volume":"348","author":"Y Goto","year":"1990","unstructured":"Goto Y, Nonaka I, Horai S: A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990, 348:651\u2013653.","journal-title":"Nature"},{"key":"96_CR41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ajmg.a.32703","volume":"149","author":"M Mehrazin","year":"2009","unstructured":"Mehrazin M, Shanske S, Kaufmann P, et al.: Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS. Am J Med Genet A 2009, 149:584\u2013587.","journal-title":"Am J Med Genet A"},{"key":"96_CR42","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/sj.ejhg.5201216","volume":"12","author":"MT McDonnell","year":"2004","unstructured":"McDonnell MT, Schaefer AM, Blakely EL: Noninvasive diagnosis of the 3243A\u2009>\u2009G mitochondrial DNA mutation using urinary epithelial cells. Eur J Hum Genet 2004, 12:778\u2013781.","journal-title":"Eur J Hum Genet"},{"key":"96_CR43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ajmg.a.30220","volume":"130","author":"S Shanske","year":"2004","unstructured":"Shanske S: Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis. Am J Med Genet 2004, 130:134\u2013137.","journal-title":"Am J Med Genet"},{"key":"96_CR44","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jocn.2008.11.012","volume":"16","author":"R Marotta","year":"2009","unstructured":"Marotta R, Reardon K, McKelvie PA, et al.: Association of the MELAS m.3243A\u2009>\u2009G mutation with myositis and the superiority of urine over muscle, blood and hair for mutation detection. J Clin Neurosci 2009, 16:1223\u20131225.","journal-title":"J Clin Neurosci"},{"key":"96_CR45","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.clineuro.2008.06.010","volume":"110","author":"FR Wiedemann","year":"2008","unstructured":"Wiedemann FR, Bartels C, Kirches E, et al.: Unusual presentations of patients with the mitochondrial MERRF mutation A8344G. Clin Neurol Neurosurg 2008, 110:859\u2013863.","journal-title":"Clin Neurol Neurosurg"},{"key":"96_CR46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/archneur.61.2.269","volume":"61","author":"MA Melone","year":"2004","unstructured":"Melone MA, Tessa A, Petrini S, et al.: Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS\/MERFF phenotype. Arch Neurol 2004, 61:269\u2013272.","journal-title":"Arch Neurol"},{"key":"96_CR47","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1056\/NEJM199909303411404","volume":"341","author":"AL Andreu","year":"1999","unstructured":"Andreu AL, Hanna MG, Reichmann H, et al.: Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med 1999, 341:1037\u20131044.","journal-title":"N Engl J Med"},{"key":"96_CR48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mito.2009.01.006","volume":"9","author":"B Bortot","year":"2009","unstructured":"Bortot B, Barbi E, Biffi S,et al.: Two novel cosegregating mutations in tRNAMet and COX III, in a patient with exercise intolerance and autoimmune polyendocrinopathy. Mitochondrion 2009, 9:123\u2013129.","journal-title":"Mitochondrion"},{"key":"96_CR49","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1212\/01.WNL.0000154471.33156.55","volume":"64","author":"T Pulkes","year":"2005","unstructured":"Pulkes T, Liolitsa D, Wills AJ, et al.: Nonsense mutations in mitochondrial DNA associated with myalgia and exercise intolerance. Neurology 2005, 64:1091\u20131092.","journal-title":"Neurology"},{"key":"96_CR50","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W","volume":"45","author":"AL Andreu","year":"1999","unstructured":"Andreu AL, Tanji K, Bruno C, et al.: Exercise intolerance due to a nonsense mutation in the mtDNA ND4 gene. Ann Neurol 1999, 45:820\u2013823.","journal-title":"Ann Neurol"},{"key":"96_CR51","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.nmd.2008.01.003","volume":"18","author":"E Downham","year":"2008","unstructured":"Downham E, Winterthun S, Nakkestad HL, et al.: A novel mitochondrial ND5 (MTND5) gene mutation giving isolated exercise intolerance. Neuromusc Disord 2008, 18:310\u2013314.","journal-title":"Neuromusc Disord"},{"key":"96_CR52","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nmd.2003.10.011","volume":"14","author":"R McFarland","year":"2004","unstructured":"McFarland R, Taylor RW, Chinnery PF, et al.: A novel sporadic mutation in cytochrome c oxidase subunit II as a cause of rhabdomyolysis. Neuromusc Disord 2004, 14:162\u2013166.","journal-title":"Neuromusc Disord"},{"key":"96_CR53","doi-asserted-by":"crossref","unstructured":"Hirano M: Metabolic myopathies. In Neurobiology of Disease. Edited by Gilman S. San Diego, CA: Elsevier Academic Press; 2007:947\u2013956.","DOI":"10.1016\/B978-012088592-3\/50088-8"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-010-0096-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-010-0096-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-010-0096-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T13:17:53Z","timestamp":1711286273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-010-0096-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,27]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1007\/s11910-010-0096-4","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,27]]}}}